Oligodendroglioma Low Grade
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

Click HERE for details on the Oligo Fund

Search Term: Oligodendroglioma Low Grade
Search results are returned below separately for clinical trials, frequently asked questions, pages on this site, and news articles - scroll down to see them all!

Trials and Noteworthy Treatments

  Treatment Next 25 Location Last Updated
Details Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Cincinnati, OH
Birmingham, AL
Phoenix, AZ
La Jolla, CA
Orange, CA
Denver, CO
Norwich, CT
Newark, DE
Jacksonville, FL
Atlanta, GA
Des Moines, IA
Chicago, IL
Wichita, KS
New Orleans, LA
Baltimore, MD
Kalamazoo, MI
Charlotte, NC
Lebanon, NH
New Brunswick, NJ
Syracuse, NY
Cleveland, OH
Cleveland, OH
Portland, OR
Philadelphia, PA
Spartanburg, SC
Rapid City, SD
Nashville, TN
Dallas, TX
Galveston, TX
Houston, TX
Saint George, UT
Salt Lake City, UT
Charlottesville, VA
Richmond, VA
Seattle, WA
Green Bay, WI
La Crosse, WI
Madison, WI
Milwaukee, WI
09/26/2012
Details A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Tumors of the Brain San Francisco, CA 04/05/2012
Details Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma Jacksonville, FL
Ames, IA
Cedar Rapids, IA
Missouri Valley, IA
Sioux City, IA
Moline, IL
Peoria, IL
Urbana, IL
Wichita, KS
Lambertville, MI
Duluth, MN
Saint Louis Park, MN
Billings, MT
Bismarck, ND
Lincoln, NE
Allentown, PA
Danville, PA
Sayre, PA
Spartanburg, SC
Rapid City, SD
Sioux Falls, SD
01/12/2010
Details A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors Bethesda, MD 04/22/2009
Details A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas Bethesda, MD 04/22/2009
Details Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors. Bethesda, MD 04/22/2009
Details Phase II Trial of RAD001 in Patients with Recurrent Low Grade Glioma San Francisco, CA 04/06/2009
Details Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection Santa Monica, CA 11/29/2008
Details Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma Charlottesville, VA 09/30/2008
Details Gliogene: An International Brain Tumor Study Houston, TX 07/24/2008
Details A Phase II Study of Temozolomide (temodar) in the Treatment of Adult Patients with Supratentorial Low Grade Glioma San Francisco, CA 10/03/2007
Details NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma Los Angeles, CA
Boston, MA
Boston, MA
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI
10/03/2007
Details Brain Mapping for Brain Tumors Boston, MA 08/18/2007
Details A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas Phoenix, AZ
New Haven, CT
Lewes, DE
Fort Lauderdale, FL
Jacksonville, FL
Jacksonville, FL
Miami, FL
Columbus, GA
Dubuque, IA
Detroit, MI
Kalamazoo, MI
Lambertville, MI
Rochester, MN
Rochester, MN
Saint Louis Park, MN
Springfield, MO
Omaha, NB
Goldsboro, NC
Lebanon, NH
Long Branch, NJ
Mount Holly, NJ
Albuquerque, NM
Buffalo, NY
Utica, NY
, OH
Akron, OH
Cleveland, OH
Tulsa, OK
Portland, OR
Philadelphia, PA
Philadelphia, PA
Wynnewood, PA
Greenville, SC
Kingsport, TN
Salt Lake City, UT
Madison, WI
05/01/2007
Details Phase II Randomized Study of Intra-Arterial Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Delayed High-Dose Sodium Thiosulfate in Patients With High-Grade Glioma Cleveland, OH
Columbus, OH
Portland, OR
05/01/2007
Details Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma Jacksonville, FL
Jacksonville, FL
Des Moines, IA
Moline, IL
Peoria, IL
Urbana, IL
Wichita, KS
Lambertville, MI
Rochester, MN
Saint Louis Park, MN
Billings, MT
Bismarck, ND
Lincoln, NE
Danville, PA
Spartanburg, SC
Sioux Falls, SD
06/26/2006
Details Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors Los Angeles, CA 05/29/2006
Details Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma Toronto, Ontario, , Canada 05/21/2006
Details Phase II Study of Temozolomide in Patients With Supratentorial Low-Grade Glioma San Francisco, CA 05/02/2006
Details Pharmacological intervention for learning impaired children surviving treatment for cancer. Durham, NC 12/03/2005
Details Gamma Knife Radiosurgery for Brain Tumors La Jolla, CA 12/03/2005
Details A Phase I dose escalation trial of Temodar that will attempt to determine the maximum tolerated dose of Temodar (Temozolomide) when given by prolonged oral exposure to children with recurrent or progressive brain tumors. New York, NY 12/03/2005
Details Gamma Knife Radiosurgery Edison, NJ 12/03/2005
Details Gamma knife stereotactic radiosurgery for benign and malignant brain tumors and brain metastases. Rockville Centre, NY 12/03/2005
Details Quality of Life Studies (There are 19 seperate studies listed here) Durham, NC 12/03/2005


News Stories



Frequently Asked Questions







Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2014 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites